Unknown

Dataset Information

0

NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies.

ABSTRACT:

SUBMITTER: Patkar N 

PROVIDER: S-EPMC7200652 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Application of RNA-Based Next-Generation Sequencing Fusion Assay for Hematological Malignancies.
| S-EPMC11765404 | biostudies-literature
Unknown Unearthing novel fusions as therapeutic targets in solid tumors using targeted RNA sequencing.
| S-EPMC9399837 | biostudies-literature
Unknown Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies.
| S-EPMC8051993 | biostudies-literature
Unknown Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies.
| S-EPMC10134288 | biostudies-literature
Unknown An accurate DNA and RNA based targeted sequencing assay for clinical detection of gene fusions in solid tumors.
| S-EPMC11870997 | biostudies-literature
Unknown [Progress in chimeric antigen receptor NK cell therapy for hematological malignancies].
| S-EPMC9939332 | biostudies-literature
Unknown Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics.
| S-EPMC7388219 | biostudies-literature
Unknown Pathogen detection by targeted next-generation sequencing test in adult hematological malignancies patients with suspected infections.
| S-EPMC11458473 | biostudies-literature
Unknown Clinical development of chimeric antigen receptor-T cell therapy for hematological malignancies.
| S-EPMC10538902 | biostudies-literature
Unknown Targeted High-throughput Sequencing for Hematological Malignancies: A GBMHM Survey of Practice and Cost Evaluation in France.
| S-EPMC10455455 | biostudies-literature